Decision | Consent granted Section 12(1)(a) Overseas Investment Act 2005 Section 13(1)(a) Overseas Investment Act 2005 Section 20A Overseas Investment Act 2005 |
---|---|
Decision Maker | Overseas Investment Office |
Decision Date | 23 May 2022 |
Pathway(s) | Residential land development (Non-residential and Incidental residential use - one-off purchase) and significant business assets. The Minister of Finance has determined that the Investment is not contrary to New Zealand’s national interest. |
Investment | An overseas investment in significant business assets, being the Applicant's acquisition of 100% of the shares in Evolution Healthcare Holdings Limited, the consideration of which exceeds $100m. An overseas investment in sensitive land, being the acquisition of interests in approximately 0.4474 hectares of residential (but not otherwise sensitive) used for medical purposes. |
Consideration for NZ assets | $723,000,000 |
Applicant | NZ Healthcare Bidco Limited Australia (71%) South Korea (17%) NZ (5%) Various (7%) |
Vendor | Existing shareholders of Evolution Healthcare Holdings Limited Various overseas persons (100%) |
Background | The Applicant is a new entity set up for the purposes of this transaction. The Applicant is predominantly owned by two Australian based underlying investment fund groups:
The Applicant is seeking consent to acquire all of the shares in healthcare provider Evolution Healthcare Holdings Limited (Target). The Target leases or owns three small residential properties used for medical purposes. The Target is currently overseas owned. The Applicant was selected as the successful bidder after a competitive process involving multiple interested parties. The proposed transaction was of national interest due to the involvement of non-NZ government investors. |
More information | Tessa Baker Chapman Tripp PO Box 2206 Auckland 1140 |
See the attached assessment report linked below, which was published in response to an Official Information Act request:
- Last updated